CRISPR-engineered T cells in patients with refractory cancer.
Science. 2020 Feb 28;367(6481):eaba7365. doi: 10.1126/science.aba7365. Epub 2020 Feb 6.
Science. 2020.
PMID: 32029687
Clinical Trial.